Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Stéphane Rinfret?

Stéphane Rinfret

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Hôpital Laval Research Centre


Web References(2 Total References)


abstract04.tctmd.com

Researchers led by Stéphane Rinfret, MD, SM, of the Hôpital Laval Research Centre (Quebec City, Canada), identified 21 eligible trials including 4,299 patients with STEMI who were randomized to primary PCI with or without thrombectomy.
Sixteen of the trials (n = 3,365) evaluated manual thrombectomy. In an e-mail communication, Dr. Rinfret told TCTMD that while the meta-analysis produced findings that were not unexpected based on the bulk of evidence, it was valuable in that it includes new trial data. The current paper adds 7 studies with 946 patients to previous analyses. Importantly, "[o]ur meta-analysis is the first to demonstrate that thrombectomy prevents no reflow," he said, proposing that this was likely due to a larger sample size. In addition, Dr. Rinfret said that the "lack of clinical impact is not that surprising, given the very low rates of adverse clinical outcomes, including death, in these trials. Dr. Rinfret, for his part, said that based on the literature it would be reasonable to perform thrombectomy alongside primary PCI but only with the goal of preventing periprocedural complications such as embolization and no reflow, not to improve short-term clinical outcomes. Thus, the technique "makes our life easier in the cath lab as interventional cardiologists, and this is an important consideration," he noted. However, Dr. Rinfret similarly stressed that thrombectomy is "not likely to be helpful in the absence of overt thrombus.


abstract04.tctmd.com

Stéphane Rinfret, MD, SM, of Université Laval (Quebec, Canada), and colleagues conducted their cost analysis using data from the EASY (Early Discharge After Transradial Stenting of Coronary Arteries) trial.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory